2000
DOI: 10.1046/j.1365-2672.2000.00985.x
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Listeria effect of enterocin A, produced by cheese-isolated Enterococcus faecium EFM01, relative to other bacteriocins from lactic acid bacteria

Abstract: Enterocin A produced by Enterococcus faecium EFM01 displayed a narrow antimicrobial spectrum, mainly directed against Listeria spp. In particular, the bacteriocin was extremely active against 13 Listeria monocytogenes strains. This high specificity of action of enterocin A for Listeria spp. relative to lactic acid bacteria, together with its broad range of activity from pH 4·0 to pH 9·0, are factors which may be of great interest with respect to the potential antilisterial use of this bacteriocin in fermented … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

3
40
0
5

Year Published

2003
2003
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(48 citation statements)
references
References 35 publications
(53 reference statements)
3
40
0
5
Order By: Relevance
“…However, since enterocins may be produced by enterococcal species carrying antibiotic resistance genes and/or genes that code for potential virulence factors, for hygienic, safety, and biotechnological reasons, the production of enterocins in other microbial hosts is being evaluated (9,20,21,22). The enterocin A (EntA) produced by Enterococcus faecium T136 (11) is a class IIa bacteriocin with high antilisterial activity (14,16). The presence of Listeria monocytogenes in food can be reduced by in situ EntA production (23,29), by the addition of semipurified or purified preparations of EntA (1,24), or by the incorporation of EntA into biodegradable packaging films (31).…”
mentioning
confidence: 99%
“…However, since enterocins may be produced by enterococcal species carrying antibiotic resistance genes and/or genes that code for potential virulence factors, for hygienic, safety, and biotechnological reasons, the production of enterocins in other microbial hosts is being evaluated (9,20,21,22). The enterocin A (EntA) produced by Enterococcus faecium T136 (11) is a class IIa bacteriocin with high antilisterial activity (14,16). The presence of Listeria monocytogenes in food can be reduced by in situ EntA production (23,29), by the addition of semipurified or purified preparations of EntA (1,24), or by the incorporation of EntA into biodegradable packaging films (31).…”
mentioning
confidence: 99%
“…The presence of enterococci in dairy products has long been considered as an indicator of inadequate sanitary conditions during the production and processing of milk. In contrast, many authors suggest that enterococci may have a potentially desirable role in some cheeses, because of their proteolytic and lipolytic activities, in the development of typical flavours and for the production of enterocins with anti-Listeria activity (Ennahar & Deschamps, 2000;Giraffa et al, 1997). The important question is whether enterococci originating from food and from community sources possess an equally pathogenic potential, or whether differences in pathogenicity exists, perhaps in relation to the different species.…”
mentioning
confidence: 99%
“…The class I bacteriocin nisin, which is commercially available as a food preservative (14), and bacteriocins of class IIa (pediocin-like) are of special interest as inhibitors of Listeria spp. (19,47). The addition of bacteriocinogenic LAB or purified bacteriocins to inhibit the growth of Listeria spp.…”
mentioning
confidence: 99%